OpenEvidence

OpenEvidence will be at #HLTH next week in Las Vegas!   Stop by booth #1936 to meet co-founder and CTO Zack Ziegler, connect with members of our clinical and engineering teams, and learn more about how OpenEvidence is transforming evidence-based clinical decision-making. Be sure to catch Zack on the main stage on Tuesday, October 21, at 2:00 pm, as he and other experts discuss how AI is transforming healthcare. 

Thank you, Jensen Huang, for the OpenEvidence callout on CNBC. NVIDIA is the fountainhead of our entire industry, and we’re honored to be included among your examples of what’s working in AI.

OpenEvidence is at AAFP FMX Conference! Come see us at booth #1642 for coffee and to learn more about how OpenEvidence is transforming evidence-based clinical decision-making for family medicine. There will be a special announcement at the main stage on Tuesday, October 7th, in the afternoon. #AAFPFMX #OpenEvidence #Healthcare

OpenEvidence featured on Bloomberg TV. 🎥 Oncologist Dr. Mullangi sits down with Bloomberg to share how she uses OpenEvidence in daily practice. 🔊 Sound on. Watch the segment.

Last week, OpenEvidence hosted our inaugural keynote event, "Medical Search in the AI Era" at Google HQ in NYC — bringing together physician leaders and healthcare innovators to explore how AI is reshaping medicine. Thank you to Google’s Dr. Peter Clardy, for joining our founder, Daniel Nadler, on stage for a fireside chat on the changes AI is bringing to the industry. And to our physician panel, Eric Collisson, MD, Vishal Patel, MD and Vivek Rudrapatna, MD (and moderator Travis Zack, MD, PhD) who talked about what those changes mean for their practice day to day. Special thanks to Sangeen Zeb and the Google Ventures team for your partnership! 

OpenEvidence is at DCI Network's "Signal Through The Noise: What Works, What Lasts, and What Matters in Healthcare AI" conference. Join us on Friday to learn more about how OpenEvidence is transforming evidence-based clinical decision-making, as well as a special announcement. #DCINetwork #OpenEvidence #Healthcare

Profile of the “other investor from Omaha,” GV (Google Ventures) Partner and OpenEvidence backer, Sangeen Zeb. Our internal code name for him is “Brother Missouri,” because as steadily, reliably, and dependably as the Missouri River flows unbroken along Omaha’s edge, Sangeen will be there for you like a brother—no matter the hour of day and no matter what you need. https://lnkd.in/gF3X4hZB

Big news: Open Evidence just became the first AI to score a perfect 100% on the US Medical Licensing Exam. OpenEvidence’s AI scored a perfect 100% on the U.S. Medical Licensing Exam, answering every question correctly and explaining the reasoning, citing gold-standard medical sources. Over 40% of U.S. physicians are currently using OpenEvidence for evidence-based clinical decision-making and practice support. Their next project? Helping students. The team is now developing tools to help medical students learn, test, and apply clinical knowledge at school with the same sources trusted by practicing physicians. We’re proud to support OpenEvidence as they help shape the future of medical care, and soon education. Congratulations to Daniel Nadler and the team on this incredible milestone!

Today our team launched OpenEvidence Visits, a new feature aimed at assisting clinicians with their patient encounters in real-time. Visits acts as a digital Clinical Assistant that enriches encounter notes with the latest clinical evidence and guidelines, assists with clinical documentation, and allows physicians to manage patient documents and ask OpenEvidence questions using the entire context of their patients' history and documentation. OpenEvidence Visits is free for all verified US Healthcare Professionals. Read more about it here:  https://lnkd.in/e7Q8pt7t

OpenEvidence will be at AAFP FUTURE this week! Stop by booth 911 for free coffee and to learn more about OpenEvidence from the team. #AAFP #FUTURE2025 #OpenEvidence #Healthcare #Innovation